Global pharma partner SkyCell serves 20 of the world’s leading pharmaceutical companies and operates a global network with 250+ airports and 50+ service stations, presenting a ready-made pathway for expanding into additional strategic pharma accounts and cross-border shipments.

Advanced cold chain The company’s zero product loss hybrid containers and 6500X multi-pallet container demonstrate a strong value proposition for high-value, temperature-sensitive therapies, suggesting opportunities to upsell to customers requiring scalable, high-performance packaging across air and ocean lanes.

Digital risk platform Validaide and the SkyCell Suite deliver end-to-end visibility and data-driven risk management across more than 60,000 lanes, enabling stronger compliance, proactive issue resolution, and potential cross-sell of additional monitoring and analytics features to existing customers.

Sustainability edge Recognized among the top 1% of sustainable companies, SkyCell’s focus on reducing emissions and building resilient supply chains aligns with pharma clients’ ESG and regulatory expectations, opening conversations around sustainability reporting, emissions reductions, and green logistics initiatives.

Strategic partnerships Recent expansion with Yusen Logistics on the China-Japan lane and ongoing high-profile investments indicate a collaborative growth strategy and potential for co-sell, co-branding, or joint go-to-market initiatives with logistics ecosystem partners.